Sorrento Therapeutics Inc (SRNE): I always find PaulSnowman's posts wo...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Monday, 02/28/2022 12:02:09 PM

Monday, February 28, 2022 12:02:09 PM

I always find PaulSnowman's posts worth reading...
" The plus Sorrento has is revenue from ZTlido and STIX. Most small Biotechs don’t have that. Add in the shares of Celularity. Then there’s the eventual approval this year of MSC (Covid), Socazolimab (China NMPA), SP102 (yes this year. For once Ji has learned his lesson and is understating the timeline to approval in my opinion), and probably a couple of more things in the pipeline (I’m looking at you Abivertinib). But for sure SP102 is a no brainer at around 99.9% chance of approval."

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM